CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
The role of Dextran on the blood level of35S-Calcium Dobesilate in humans
Authors
Ch.-T. Plessas Varonos, D. Plessas, S.T. Cokkinos, D. Voridis, E.
Publication date
1 January 1976
Publisher
Abstract
The concomitant administration of Dextran and Calcium Dobesilate might be foreseen in clinical practice since the former is used as a blood volume restorer, and the latter as a protector of the capillary blood vessel walls. The aim of this study is to investigate if the intravenous administration of Dextran is liable to influence the pharmacokinetics of orally administrated 35S Calcium Dobesilate. The maximum blood level values in the group treated simultaneously with Calcium Dobesilate and Dextran were similar to those obtained after the administration of Calcium Dobesilate alone. The rate of protein binding was practically identical in both Dextran-treated groups, whether Calcium Dobesilate was given before or after Dextran. This experiment showed that Dextran does not affect the blood level of Calcium Dobesilate in man. © 1976 Springer-Verlag
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3023889
Last time updated on 10/02/2023